COVID-19 Updates

COVID-19: Our Response and Path Forward

Statement from CEO and Chairman, Giovanni Caforio, M.D. 

Bristol Myers Squibb recognizes COVID-19 has created unique challenges for each of us. We are focused on protecting our workforce’s health and safety, ensuring a continued supply of our medicines to patients and supporting relief efforts across the globe. We will take all necessary actions to promote public health and carry out our mission of providing life-saving medicines to patients who depend on us. We will continue to operate with compassion, diligence and patience to meet the needs of all of our stakeholders as the environment in which we operate continues to evolve.

The Path to Delivering Our Mission in a New Environment  

Our Principles

More on Our Response

Patient Support Program

(toll free U.S. only)

Clinical Trial Investigators

Clinical Trial Investigators

Latest update on July 31, 2020

Media

Media

Investors

Investors


Frequently 
Asked Questions

How is the COVID-19 pandemic affecting the supply of Bristol Myers Squibb medicines?

What patient support programs are available for patients during this time? 

How is COVID-19 affecting Bristol Myers Squibb clinical trials and ongoing research efforts?

What is Bristol Myers Squibb’s approach to returning its broader workforce to sites and the field? 

How is Bristol Myers Squibb protecting healthcare providers?

Where can patients go for questions about COVID-19 treatment and Bristol Myers Squibb medicines?

How is Bristol Myers Squibb contributing to the global relief efforts for COVID-19?

How is Bristol Myers Squibb contributing to COVID-19 research efforts and helping to identify and accelerate treatment options for COVID-19? 

How do I reach the media team at Bristol Myers Squibb?

Where can I find more information about how the pharmaceutical industry’s response to COVID-19?

Where can I go for more information about COVID-19?

Last Updated On: August 4, 2020